Parasitic tapeworm larvae release glutamate and other excitatory molecules that can directly excite brain neurons.

Prince also cites divine intervention for helping him cope with his epilepsy. “My mother told me one day I walked in to her and said, ‘Mom, I’m not going to be sick anymore,’ and she said ...

Ipsen has signed yet another portfolio-expanding deal – its fifth of the year so far – claiming rights outside the US to a drug for common brain cancer glioma from Day One Biopharmaceuticals.

Servier’s $1.8bn Agios deal delivers glioma prospect Servier looks like it could bring a second IDH inhibitor from its 2021 takeover of Agios’ oncology business to market, after reporting ...

FDA approves smartwatch for epilepsy monitoringA new smart watch which uses machine learning to monitor for the most dangerous kinds of epileptic seizures has been approved by the FDA. Cambridge ...

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster.

Epilepsy refers to a group of neurological disorders of varying aetiology, characterized by recurrent brain dysfunction that result from sudden excessive and disordered neuronal discharge.

People with a form of severe epilepsy will now be able to get NHS access to a new drug from UCB, Fintepla, that could significantly reduce their seizures. The NHS will fund Fintepla (fenfluramine ...

GRIN raises $140m for epilepsy drug, and other financings Our round-up of recent biotech financings is headed by a $140 million Series D for GRIN Therapeutics, which also scored a $570 million ...